"Integrated Innovation, Stepping into the Future" - 2024 Seminar on Approaching Morimatsu Wraps Up

MORIMATSU OPEN DAY

Integrated Innovation, Stepping into the Future

On October 17, the "Integrated Innovation, Stepping into the Future" - 2024 Seminar on Approaching Morimatsu was held by Morimatsu LifeSciences in Changshu Manufacturing Base.

At this conference, invited industry experts shared their experience with Morimatsu experts. Professionals from the production, R&D, procurement, quality control and other positions of pharmaceutical and biopharmaceutical enterprises, as well as nearly 100 guests from the Service of Societies of "Innovation China" & Alumni Association of the Biomedical Industry at East China University of Science and Technology participated in the event to exchange and discuss the future development trend of the biomedical industry. We would like to express our special thanks to our friendly sponsors, Jiangsu GeneIII Biotechnology Co., Ltd. and WeCare Probiotics (Suzhou) Co., Ltd., for their strong support of this event.

The booming development trend is evident in the biopharmaceutical industry, driven by the wave of new technologies and influenced by diversified demands and application scenarios. Mr. Gao Yang, Deputy General Manager of Shanghai Morimatsu Biotechnology Co., Ltd., presided over the conference, and five guests brought wonderful topics.

First of all, Mr. Jiang Pei, Senior Vice President of Morimatsu LifeSciences, delivered a speech and introduced Changshu Plant; Prof. Guo Meijin from East China University of Science and Technology, Mr. Duan Zhiguang, Chief Technology Officer of Giant Biogene, Mr. Zhou Xinhua, Chief Scientific Officer of Biometa/CEO of Bainuo Yintai, Mr. He Guolun, Deputy General Manager and Mr. Wan Xun, Technical Director of Morimatsu Biotechnology, have explored hot topics and trends in the industry around intelligent biofabrication technology, biofabrication and application research of recombinant collagen, the power of artificial intelligence to miRNA pharmaceutical platforms, and design considerations for full-scale magnified bioreactors, they clash ideas and share insights through discussion and exchange; at the same time, the latest achievements and solutions of Morimatsu in the field of biomedicine were also showcased to the public.

From these sharing, the participants not only mastered the cutting-edge news and future trends of biomedical technology, but also drew rich inspiration and wisdom, so that the new mind for future research directions and innovation paths have been broaden, and the process of innovation and practical application of biomedical technology has been accelerated.

After the discussion, the attending guests went to visit the workshop. Entering this modern factory that integrates automation, intelligence, and sustainability, they gained a more intuitive understanding of the strength in R&D, manufacturing, process technology, and quality control of Morimatsu.

After the visit, the guests came to the exhibition hall to learn more about the corporate philosophy, development history and technological achievements of Morimatsu.